ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Quantum Biopharma Ltd

Quantum Biopharma Ltd (QNTM)

4,89
0,38
(8,43%)
Geschlossen 16 März 9:00PM
5,6999
0,8099
(16,56%)
Nach Börsenschluss: 12:59AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
5,6999
Gebot
5,51
Fragen
6,02
Volumen
246.032
4,60 Tagesbereich 5,20
2,70 52-Wochen-Bereich 18,00
Marktkapitalisierung
Handelsende
4,51
Handelsbeginn
4,80
Letzte Trade
20
@
5.69
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.183.202
VWAP
4,8091
Durchschnittliches Volumen (3 Mio.)
2.681.078
Ausgegebene Aktien
1.300.480
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,01
Gewinn pro Aktie (EPS)
-13,77
Erlöse
-
Nettogewinn
-17,9M

Über Quantum Biopharma Ltd

Quantum Biopharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its w... Quantum Biopharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly-owned subsidiary, Lucid Psycheceuticals Inc. ('Lucid'), Quantum Biopharma is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) ('Lucid-MS'). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum Biopharma has also licensed unbuzzd(TM), a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. ('Celly Nu'). Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Toronto, Ontario, Can
Gegründet
-
Quantum Biopharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker QNTM. The last closing price for Quantum Biopharma was US$4,51. Over the last year, Quantum Biopharma shares have traded in a share price range of US$ 2,70 to US$ 18,00.

Quantum Biopharma currently has 1.300.480 shares in issue. The market capitalisation of Quantum Biopharma is US$5,87 million. Quantum Biopharma has a price to earnings ratio (PE ratio) of -0.01.

QNTM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.319930.13470319634.386.154.2495794.55507172CS
4-4.9301-46.379115710310.6310.634.041846746.24516323CS
121.679941.78855721394.02182.726810788.96731596CS
261.789945.77749360613.91182.712300118.79050553CS
520.799916.32448979594.9182.711079718.55800647CS
1560.799916.32448979594.9182.711079718.55800647CS
2600.799916.32448979594.9182.711079718.55800647CS

QNTM - Frequently Asked Questions (FAQ)

What is the current Quantum Biopharma share price?
The current share price of Quantum Biopharma is US$ 5,6999
How many Quantum Biopharma shares are in issue?
Quantum Biopharma has 1.300.480 shares in issue
What is the market cap of Quantum Biopharma?
The market capitalisation of Quantum Biopharma is USD 5,87M
What is the 1 year trading range for Quantum Biopharma share price?
Quantum Biopharma has traded in the range of US$ 2,70 to US$ 18,00 during the past year
What is the PE ratio of Quantum Biopharma?
The price to earnings ratio of Quantum Biopharma is -0,01
What is the reporting currency for Quantum Biopharma?
Quantum Biopharma reports financial results in USD
What is the latest annual profit for Quantum Biopharma?
The latest annual profit of Quantum Biopharma is USD -17,9M
What is the registered address of Quantum Biopharma?
The registered address for Quantum Biopharma is 199 BAY STREET, SUITE 4000, TORONTO, ONTARIO, M5L 1A9
What is the Quantum Biopharma website address?
The website address for Quantum Biopharma is www.fsdpharma.com
Which industry sector does Quantum Biopharma operate in?
Quantum Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock